Cite
Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomas.
MLA
Sönmez, Cüneyt, et al. “Blockade of Inhibitory Killer Cell Immunoglobulin-like Receptors and IL-2 Triggering Reverses the Functional Hypoactivity of Tumor-Derived NK-Cells in Glioblastomas.” Scientific Reports, vol. 12, no. 1, Apr. 2022, pp. 1–11. EBSCOhost, https://doi.org/10.1038/s41598-022-10680-4.
APA
Sönmez, C., Wölfer, J., Holling, M., Brokinkel, B., Stummer, W., Wiendl, H., Thomas, C., Schulte-Mecklenbeck, A., & Grauer, O. M. (2022). Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomas. Scientific Reports, 12(1), 1–11. https://doi.org/10.1038/s41598-022-10680-4
Chicago
Sönmez, Cüneyt, Johannes Wölfer, Markus Holling, Benjamin Brokinkel, Walter Stummer, Heinz Wiendl, Christian Thomas, Andreas Schulte-Mecklenbeck, and Oliver M. Grauer. 2022. “Blockade of Inhibitory Killer Cell Immunoglobulin-like Receptors and IL-2 Triggering Reverses the Functional Hypoactivity of Tumor-Derived NK-Cells in Glioblastomas.” Scientific Reports 12 (1): 1–11. doi:10.1038/s41598-022-10680-4.